Galapagos reported €575.49M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
AstraZeneca AZN:LN 23649M 1427M
Biogen BIIB:US $ 4211.6M 864.4M
Genmab GEN:DC DK 1830M 479M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 9.08B 646M
Hikma Pharmaceutical HIK:LN 960M 68M
Merck MRK:GR € 9793M 27M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NOVN:VX SF 29880M 247M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
YTE INCY:US $ 742.71M 82.39M